Premas Biotech secures licensing deal for commercializing its vaccine technology in India

Aug 03, 2021

Gurugram (Haryana) [India], August 3 (ANI/BusinessWire India): Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, today announced that it has signed a...

Oravax and Genomma Lab announce JV to commercialize oral COVID-19 vaccine in Mexico and Latin America

Nov 20, 2021

Gurugram (Haryana) [India], November 20 (ANI/BusinessWire India): Premas Biotech together with their partners Oramed Pharmaceuticals Inc. (Nasdaq/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused...

Premas Biotech reports positive preliminary Phase-1 data for its oral Covid-19 vaccine, developed for Oravax Medical

Oct 08, 2022

Gurugram (Haryana) [India], October 8 (ANI/PRNewswire): Premas Biotech, developer of technologies & bioprocesses for novel proteins, today announced that Oravax Medical Inc., a US-based...